Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Solifenacin

Solifenacin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Solifenacin

25 trials tracked of Solifenacin: 18 in phase 3 or 4 and 1 with published results. The most-cited published study has 4 citations.

25Trials tracked
18Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 11 Phase 3 7 Phase 2 4 Other / NA 3
  1. Phase 3 Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease Completed · 4 cited
  2. Phase 4 Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. Completed
  3. Phase 4 Validation of a Real-time Urodynamic Measure of Urinary Urgency Completed
  4. Phase 4 Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life Completed
  5. Phase 4 Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease Completed
  6. Phase 4 Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms Completed
Show 19 more trials
  1. Phase 4 A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients Completed
  2. Phase 4 A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy Completed
  3. Phase 4 A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability Completed
  4. Phase 4 The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB) Completed
  5. Phase 4 Incontinence & Intimate Partners: Assessing the Contribution of Treatment Completed
  6. Phase 4 Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) Completed
  7. Phase 3 A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity Completed
  8. Phase 3 A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO) Completed
  9. Phase 3 A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. Completed
  10. Phase 3 This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder Completed
  11. Phase 3 A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder Completed
  12. Phase 3 A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence Completed
  13. Phase 2 A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder Completed
  14. Phase 2 Bacterial Genomic Sequencing in Overactive Bladder Completed
  15. Phase 2 Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction Completed
  16. Phase 2 A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type Completed
  17. N/A Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary Incontinence Completed
  18. N/A The Effect of Solifenacin on Post Void Dribbling in Women Completed
  19. N/A Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.